Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Beclomethasone Dipropionate HFA in Asthma
NCT04051710Phase 3Completed
- Sponsor
- Aurobindo Pharma Limited
- Start
- Mar 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate in asthma (3 arms), sponsored by Aurobindo Pharma Limited. Primary endpoint: Change in FEV1 From Pre Dose to End of Treatment at 4 weeks. Started Mar 2019; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04051710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04051710.